CombiMatrix Corporation has formed a wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc., to take advantage of CombiMatrix's unique approach to microarray-based diagnostics.
"CombiMatrix believes DNA microarrays are the future of diagnostics and personalized medicine. Because these are the earliest days of this future, it is a time of exceptional opportunity. CombiMatrix has a unique approach to this opportunity, and we are moving now to capitalize on it through the formation of CMD," said Dr. Amit Kumar, President and CEO of CombiMatrix.